Steven Meehan
Director of Finance/CFO at KADMON HOLDINGS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Steven N. Gordon | M | 56 |
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 11 years |
| Harlan Waksal | M | 71 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 11 years |
| Anastasios Konidaris | M | 57 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 7 years |
| Thomas Shenk | M | 77 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 6 years |
| Eugene Bauer | M | 81 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 14 years |
| Dixon Boardman | M | - |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 11 years |
| Alexandria Forbes | M | 59 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 14 years |
| Bart M. Schwartz | M | 77 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 9 years |
| Susan Wiviott | F | 66 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 10 years |
| John Allison | M | 75 | 9 years | |
| John Ryan | M | 80 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 13 years |
| David Cohen | M | 59 | 5 years | |
| Kenneth Shropshire | M | 69 | 10 years | |
| Cynthia Flowers | F | 64 | 5 years | |
| Eric Cantor | M | 60 | 10 years | |
| Gustavo J. Pesquin | M | 54 | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gregory S. Moss | M | 40 | 10 years | |
| Arthur Kirsch | M | 72 | 2 years | |
| Steven F. Bollenbach | M | 81 | 1 years | |
| Nancy Miller-Rich | F | 65 | - | |
| Konstantin Poukalov | M | 40 | 6 years | |
| Yvonne Greenstreet | M | 61 | 3 years | |
| Sheng Da Zan | M | 61 | 3 years | |
| Frank Amato | M | - | 3 years | |
| Kyle Carver | M | - | 8 years | |
| Kevin Cai | M | - | 2 years | |
| Mitch Jacobson | M | - | 2 years | |
| Brianne Jahn | M | 38 | 8 years | |
| Haya Taitel | M | 61 | 3 years | |
| Alexander Amezquita | M | 51 | 5 years | |
| Simon Cooper | M | 55 | - | |
| Christopher Cheung | M | - | 2 years | |
| Conor Sutherland | M | 36 | 2 years | |
| Will Botha | M | - | 2 years | |
| Alessandro Mora | M | - |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 2 years |
| K Fletcher | M | - |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 3 years |
| Jonathan Szwec | M | - | 1 years | |
| David Xia | M | - | 2 years | |
| Zack Coleman | M | - | 2 years | |
| Charles E. Darder | M | - | - | |
| Ben Reitzes | M | 51 | - | |
| David Cheyne | M | - | 4 years | |
| Lawrence K. Cohen | M | 70 | 3 years | |
| Joseph Chow | M | 60 | - | |
| Jared E. Becker | M | - | 2 years | |
| Daniel T. Motulsky | M | 62 | 4 years | |
| Russell Kelley | M | 48 | 3 years | |
| Robert LaRoche | M | 33 | 2 years | |
| Sebastian Kolbe | M | - | 2 years | |
| Nadim Lahoud | M | - | 2 years | |
| Joshua B. Sacks | M | - | 1 years | |
| Elliot Richmond | M | 45 | 8 years | |
| Mijana Djurdjevic | F | - | 2 years | |
| Daniel Cohen | M | 36 | 2 years | |
| Maarten de Jong | M | - | 9 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 55 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Steven Meehan
- Personal Network
